Page last updated: 2024-09-04

resiquimod and Precancerous Conditions

resiquimod has been researched along with Precancerous Conditions in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hengge, UR; Meykadeh, N1
Bichel, J; Lee, J; Meng, TC; Ortonne, JP; Stockfleth, E; Szeimies, RM1

Trials

1 trial(s) available for resiquimod and Precancerous Conditions

ArticleYear
A phase II dose-ranging study of topical resiquimod to treat actinic keratosis.
    The British journal of dermatology, 2008, Volume: 159, Issue:1

    Topics: Administration, Topical; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gels; Humans; Imidazoles; Keratosis; Male; Precancerous Conditions; Severity of Illness Index; Skin Neoplasms; Toll-Like Receptor 7; Treatment Outcome; Up-Regulation

2008

Other Studies

1 other study(ies) available for resiquimod and Precancerous Conditions

ArticleYear
[Topical immunomodulators in dermatology].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts

2003